Kathleen Beusterien

ORCID: 0000-0001-7786-5422 · 2 papers in corpus

article 2025

Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States

Women's health (London, England) ·doi:10.1177/17455057251331700

BACKGROUND: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, an…

article 2022

P-315 The importance of treatment features beyond pain reduction associated with gonadotropin-releasing hormone analogues from the patient perspective

·doi:10.1093/humrep/deac107.300

Abstract Study question Beyond reducing pain, how do women with moderate-severe-endometriosis pain prioritize treatment features and outcomes associated with gonadotropin-releasing hormone (GnRH) analogues? Summary answer Moderate-severe-en…